HOUSTON, July 29, 2024 /PRNewswire/ -- Nutex Health
Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a
physician-led, technology-enabled integrated healthcare delivery
system comprised of 21 state-of-the-art micro hospitals in 9 states
and primary care-centric, risk-bearing physician networks,
announced today that it has received formal notice from
The Nasdaq Stock Market LLC ("Nasdaq") indicating that the
Company has regained compliance with the minimum bid price
requirement set forth in Nasdaq Listing Rule 5550(a)(2) for
continued listing on the Nasdaq Capital Market as required by the
Hearing Panel's June 14, 2024
decision, as previously disclosed in the Company's Current Report
on Form 8-K filed on June 18,
2024.
The Nasdaq staff made this determination of compliance after the
closing bid price of the Company's common stock traded above
$1.00 per share from July 3, 2024, the date of the Company's 1:10
reverse stock split, to July 23,
2024. Accordingly, Nasdaq has determined that the Company
has regained compliance with Listing Rule 5550(a)(2) and Nasdaq
considers the prior bid price deficiency matter now closed.
About Nutex Health Inc.
Headquartered in Houston, Texas
and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a
healthcare management and operations company with two divisions: a
Hospital Division and a Population Health Management Division.
The Hospital Division owns, develops and operates innovative
health care models, including micro-hospitals, specialty hospitals,
and hospital outpatient departments (HOPDs). This division owns and
operates 21 facilities in 9 states.
The Population Health Management division owns and operates
provider networks such as Independent Physician Associations
(IPAs). We provide management, administrative and other
support services to our affiliated hospitals and physician
groups. Our cloud-based proprietary technology platform
aggregates clinical and claims data across multiple settings,
information systems and sources to create a holistic view of
patients and providers, allowing us to deliver greater quality care
more efficiently.
Forward-Looking Statements
Certain statements and information included in this press
release constitute "forward-looking statements" within the meaning
of the Private Securities Litigation Act of 1995. When used in this
press release, the words or phrases "will", "will likely result,"
"expected to," "will continue," "anticipated," "estimate,"
"projected," "intend," "goal," or similar expressions are intended
to identify "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
are subject to certain risks, known and unknown, and uncertainties,
many of which are beyond the control of the Company. Such
uncertainties and risks include, but are not limited to, our
ability to successfully execute our growth strategy, changes in
laws or regulations, including the interim final and final rules
implemented under the No Surprises Act, economic conditions,
dependence on management, dilution to stockholders, lack of
capital, the effects of rapid growth upon the Company and the
ability of management to effectively respond to the growth and
demand for products and services of the Company, newly developing
technologies, the Company's ability to compete, conflicts of
interest in related party transactions, regulatory matters,
protection of technology, lack of industry standards, the effects
of competition and the ability of the Company to obtain future
financing. An extensive list of factors that can affect future
results are discussed in the Annual Report on Form 10-K for the
year ended December 31, 2023
and its Current Report on Form 10-Q for
the periods ended March 31, 2024 under the
heading "Risk Factors" in Part I, Item IA thereof, and other
documents filed from time to time with the Securities and Exchange
Commission. Such factors could materially adversely affect the
Company's financial performance and could cause the Company's
actual results for future periods to differ materially from any
opinions or statements expressed within this press release.
View original
content:https://www.prnewswire.com/news-releases/nutex-health-regains-compliance-with-nasdaq-minimum-bid-price-302207876.html
SOURCE Nutex Health, Inc.